Cargando…
Reversal of pre-existing NGFR-driven tumor and immune therapy resistance
Melanomas can switch to a dedifferentiated cell state upon exposure to cytotoxic T cells. However, it is unclear whether such tumor cells pre-exist in patients and whether they can be resensitized to immunotherapy. Here, we chronically expose (patient-derived) melanoma cell lines to differentiation...
Autores principales: | Boshuizen, Julia, Vredevoogd, David W., Krijgsman, Oscar, Ligtenberg, Maarten A., Blankenstein, Stephanie, de Bruijn, Beaunelle, Frederick, Dennie T., Kenski, Juliana C. N., Parren, Mara, Brüggemann, Marieke, Madu, Max F., Rozeman, Elisa A., Song, Ji-Ying, Horlings, Hugo M., Blank, Christian U., van Akkooi, Alexander C. J., Flaherty, Keith T., Boland, Genevieve M., Peeper, Daniel S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414147/ https://www.ncbi.nlm.nih.gov/pubmed/32770055 http://dx.doi.org/10.1038/s41467-020-17739-8 |
Ejemplares similares
-
Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance
por: Boshuizen, Julia, et al.
Publicado: (2023) -
Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signaling
por: Apriamashvili, Georgi, et al.
Publicado: (2022) -
An adverse tumor-protective effect of IDO1 inhibition
por: Kenski, Juliana C.N., et al.
Publicado: (2023) -
Heterogeneity in functional genetic screens: friend or foe?
por: Vredevoogd, David W., et al.
Publicado: (2023) -
RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cells
por: Zhang, Zhengkui, et al.
Publicado: (2022)